journal article·2016-04-02

Magnetic nanoparticles as potential candidates for biomedical and biological applications

Fatemeh Zeinali Sehrig, Sima Majidi, Nasrin Nikzamir, Nasim Nikzamir, Mohammad Nikzamir, Abolfazl Akbarzadeh

Publisher page

Abstract

Magnetic iron oxide nanoparticles have become the main candidates for biomedical and biological applications, and the application of small iron oxide nanoparticles in in vitro diagnostics has been practiced for about half a century. Magnetic nanoparticles (MNPs), in combination with an external magnetic field and/or magnetizable grafts, allow the delivery of particles to the chosen target area, fix them at the local site while the medication is released, and act locally. In this review, we focus mostly on the potential use of MNPs for biomedical and biotechnological applications, and the improvements made in using these nanoparticles (NPs) in biological applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Iron oxide chemistry and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

,

References (100+)

Show source-provided references
1. 10.1186/1556-276X-9-24710.1186/1556-276X-9-247 ↗
2. 10.1007/s11033-013-3014-410.1007/s11033-013-3014-4 ↗
3. 10.1186/1556-276X-7-14410.1186/1556-276X-7-144 ↗
4. Akbarzadeh A, Mikaeili H, Zarghami N, Mohammad R, Barkhordari A, Davaran S. 2012. Preparation and in vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers. Int J Nanomedicine 7:511.
5. 10.1007/s10544-009-9284-x10.1007/s10544-009-9284-x ↗
6. 10.1208/s12248-009-9143-y10.1208/s12248-009-9143-y ↗
7. 10.1148/radiol.229302121510.1148/radiol.2293021215 ↗
8. 10.1088/0022-3727/35/6/20110.1088/0022-3727/35/6/201 ↗
9. 10.1063/1.218585010.1063/1.2185850 ↗
10. 10.1088/0022-3727/36/13/20310.1088/0022-3727/36/13/203 ↗
11. 10.1016/j.addr.2005.12.00610.1016/j.addr.2005.12.006 ↗
12. Chin SF, Pang SC, Ching HT. 2011. Green synthesis of magnetite nanoparticles (via thermal decomposition method) with controllable size and shape. J Mater Environ Sci. 2:299–302.
13. Corchero JL, Seras J, Garcia-Fruitos E, Vazquez E, Villaverde A. 2010. Nanoparticle assisted tissue engineering. Biotech Int. 22:13–16.
14. 10.1016/j.tibtech.2009.04.00310.1016/j.tibtech.2009.04.003 ↗
15. 10.4236/jeas.2013.3401310.4236/jeas.2013.34013 ↗
16. 10.4236/anp.2014.3100310.4236/anp.2014.31003 ↗
17. 10.1002/ddr.2006710.1002/ddr.20067 ↗
18. Ebrahimi E, Khandaghi AA, Valipour F, Babaie S, Asghari F, Motaali S, et al. 2014. In vitro study and characterization of doxorubicin-loaded magnetic nanoparticles modified with biodegradable copolymers. Artif Cells Nanomed Biotechnol Early Online:1–9
19. Ebrahimnezhad Z, Zarghami N, Keyhani M, Amirsaadat S, Akbarzadeh A, Rahmati M, et al. 2013. Inhibition of hTERT gene expression by silibinin-loaded PLGA-PEG-Fe3O4 in T47D breast cancer cell line. BioImpacts. 3:67–74
20. Elster AD, Burdette JH. 1994. Questions and answers in magnetic resonance imaging. St. Louis, MO: Mosby.
21. 10.1039/c0jm02081h10.1039/c0jm02081h ↗
22. 10.1007/BF0324585610.1007/BF03245856 ↗
23. 10.1021/la803079210.1021/la8030792 ↗
24. 10.1038/nbt99410.1038/nbt994 ↗
25. 10.1021/jp057562v10.1021/jp057562v ↗
26. Ghanbari P, Mohseni M, Tabasinezhad M, Yousefi B, Saei AA, Sharifi S, et al. 2014. Inhibition of survivin restores the sensitivity of breast cancer cells to Docetaxel and Vinblastine. Appl Biochem Biotechnol. [Epub ahead of print].10.1007/s12010-014-1125-6 ↗
27. 10.7314/APJCP.2013.14.11.694910.7314/APJCP.2013.14.11.6949 ↗
28. 10.1097/00000658-195710000-0000710.1097/00000658-195710000-00007 ↗
29. 10.1126/science.812824510.1126/science.8128245 ↗
30. Gu H, Xu KM, Xu CJ, Xu B. 2006. Biofunctional magnetic nanoparticles for protein separation and pathogen detection. Chem Commun. 941–949.
31. 10.1016/j.biomaterials.2004.10.01210.1016/j.biomaterials.2004.10.012 ↗
32. 10.1016/j.jmmm.2006.10.115610.1016/j.jmmm.2006.10.1156 ↗
33. Hilger I Hergt R Kaiser WA. 2005. Use of magnetic nanoparticle heating in the treatment of breast cancer. in IEE Proceedings- Nanobiotechnology. IET.10.1049/ip-nbt:20055018 ↗
34. 10.1021/cm980350910.1021/cm9803509 ↗
35. 10.1002/jssc.20070008810.1002/jssc.200700088 ↗
36. 10.1038/nnano.2010.12510.1038/nnano.2010.125 ↗
37. 10.1063/1.155620410.1063/1.1556204 ↗
38. Hyeon T. 2003. Chemical synthesis of magnetic nanoparticles. Chem Commun. 927–934.
39. 10.1263/jbb.100.110.1263/jbb.100.1 ↗
40. 10.1089/107632704134830110.1089/1076327041348301 ↗
41. 10.1002/adma.20060067410.1002/adma.200600674 ↗
42. 10.1016/S0304-8853(99)00088-810.1016/S0304-8853(99)00088-8 ↗
43. Joubert JC. 1997. Magnetic micro composites as vectors for bioactive agents: the state of art. Cancer Research 56:4686–4693.
44. Jun Y, Lee JH, Cheon J. 2008. Chemical design of nanoparticle probes for high performance magnetic resonance imaging. Angew Chem Int Ed Engl. 47:5122–5135.10.1002/anie.200701674 ↗
45. Kaparissides C, Alexandridou S, Kotti K, Chaitidou S. 2006. Recent advances in novel drug delivery systems. J Nanotechnol Online. 2:1–11.
46. 10.2174/138920105316715810.2174/1389201053167158 ↗
47. Khaki-Khatibi F, Samadi N, Rahnema B, Asgharzade M, Rahbani-Nobar M, Vatankhah A. 2013. Association between nucleotide mutation of eNOS gene and serum level of vessel expansion factor (VEF) in non-smoker patients with vascular heart disease. Afr J Biotechnol. 28–30:23.
48. Khalili H, Sheikhbabayi M, Samadi N, Jamalifar H, Dalili D, Samadi N. 2013. Bacterial contamination of single- and multiple-dose vials after multiple use and intravenous admixtures in three different hospitals in iran. Iran J Pharm Res. 12:205–209.
49. 10.1002/adfm.20080184410.1002/adfm.200801844 ↗
50. 10.1016/j.ces.2005.05.06710.1016/j.ces.2005.05.067 ↗
51. 10.1002/ange.20060247110.1002/ange.200602471 ↗
52. Kotitz R, Trahms L Koch H, Weitschies W 1995. Ferrofluid relaxation for biomagnetic imaging. Biomagnetism.785–788.
53. 10.1186/1556-276X-9-13110.1186/1556-276X-9-131 ↗
54. 10.1002/biot.20090004910.1002/biot.200900049 ↗
55. 10.1021/ja074633q10.1021/ja074633q ↗
56. 10.1016/S1369-7021(05)00893-X10.1016/S1369-7021(05)00893-X ↗
57. 10.1080/0284185970917439110.1080/02841859709174391 ↗
58. 10.1016/j.jallcom.2007.11.10010.1016/j.jallcom.2007.11.100 ↗
59. 10.1016/S0038-1098(03)00580-510.1016/S0038-1098(03)00580-5 ↗
60. 10.1016/S0304-8853(00)01254-310.1016/S0304-8853(00)01254-3 ↗
61. Liu X, Zhong Z, Tang Y, Liang B 2013. Review on the synthesis and applications of nanomaterials. J Nanomater.
62. Livingston JD. 1996. Driving force: the natural magic of magnets. Cambridge, Massachusetts: Harvard University Press.
63. Lu A-H, EeL Salabas, Schuth F. 2007. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed Engl. 46:1222–1244.10.1002/anie.200602866 ↗
64. 10.3390/molecules1807753310.3390/molecules18077533 ↗
65. 10.1186/1477-044X-2-310.1186/1477-044X-2-3 ↗
66. 10.1016/j.gene.2012.09.01410.1016/j.gene.2012.09.014 ↗
67. 10.1021/la035648e10.1021/la035648e ↗
68. 10.1016/j.bbrc.2005.06.20410.1016/j.bbrc.2005.06.204 ↗
69. 10.1016/S0168-3659(99)00114-510.1016/S0168-3659(99)00114-5 ↗
70. Neel L 1949. Influence of thermal fluctuations on the magnetization of ferromagnetic small particles. CR Acad Sci. 228:664–668.
71. 10.1007/s12034-008-0016-210.1007/s12034-008-0016-2 ↗
72. 10.1088/0022-3727/36/13/20110.1088/0022-3727/36/13/201 ↗
73. 10.1021/nl035172j10.1021/nl035172j ↗
74. 10.1186/1556-276X-8-48510.1186/1556-276X-8-485 ↗
75. Pourhassan-Moghaddam M, Zarghami N, Mohsenifar A, Rahmati-Yamchi M, Gholizadeh D, Akbarzadeh A, et al. 2014. Watercress-based gold nanoparticles: biosynthesis, mechanism of formation and study of their biocompatibility in vitro. IET Dig Lib. 4:5
76. 10.1039/b708342d10.1039/b708342d ↗
77. 10.1016/j.biomaterials.2012.11.04010.1016/j.biomaterials.2012.11.040 ↗
78. 10.1021/ja993280v10.1021/ja993280v ↗
79. 10.1021/bp030070k10.1021/bp030070k ↗
80. 10.1016/j.biotechadv.2005.05.00110.1016/j.biotechadv.2005.05.001 ↗
81. 10.1016/j.chroma.2007.05.10910.1016/j.chroma.2007.05.109 ↗
82. Rosensweig RE. 1994. Ferrohydrodynamics Cambridge University Press, Cambridge, England, 1985. In: Berkovsky B, Khartov M, Eds. 28 Magnetic Fluids and Applications Handbook. Phys. Rev. Lett. 72: 1929–1939. New York: Begell House.
83. 10.1007/s00216-004-2770-310.1007/s00216-004-2770-3 ↗
84. 10.7314/APJCP.2014.15.2.51710.7314/APJCP.2014.15.2.517 ↗
85. Safarik I, Horska K Safarikova. M. 2011. Magnetic nanoparticles for biomedicine. In: Intracellular Delivery. Berlin: Springer, pp. 363–372.10.1007/978-94-007-1248-5_13 ↗
86. Santana SDF. 2011. Magnetic nanoparticles for biocatalysis and bioseparation. Faculdade de Ci ncias e Tecnologia, 1–135.
87. 10.1002/smll.20090038910.1002/smll.200900389 ↗
88. 10.1263/jbb.103.47210.1263/jbb.103.472 ↗
89. 10.1263/jbb.104.17110.1263/jbb.104.171 ↗
90. Silva A, Silva-Freitas E, Carvalho J, Pontes T, Araújo-Neto R, Silva K, et al. 2012. Magnetic particles in biotechnology: from drug targeting to tissue engineering. Adv Appl Biotechnol.10.5772/30624 ↗
91. 10.1016/j.trac.2006.03.00810.1016/j.trac.2006.03.008 ↗
92. 10.1088/0370-1298/62/9/30310.1088/0370-1298/62/9/303 ↗
93. 10.1016/j.procbio.2004.06.05010.1016/j.procbio.2004.06.050 ↗
94. 10.1021/ja209245v10.1021/ja209245v ↗
95. 10.1002/jbm.a.3090910.1002/jbm.a.30909 ↗
96. 10.1126/science.287.5460.198910.1126/science.287.5460.1989 ↗
97. 10.4103/0973-1482.12644610.4103/0973-1482.126446 ↗
98. 10.1088/0022-3727/36/13/20210.1088/0022-3727/36/13/202 ↗
99. 10.1002/cmmi.14610.1002/cmmi.146 ↗
100. 10.1128/AEM.70.5.3047-3054.200410.1128/AEM.70.5.3047-3054.2004 ↗